Regulatory authorities review use of galantamine in mild cognitive impairment.
Mayor
Susan
S
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000188:drug therapy*; D017277:Drug Approval; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D006113:United Kingdom
D002800:Cholinesterase Inhibitors; D005702:Galantamine